MilWealth Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36
Closed -$17.7K 75
2022
Q1
$17.7K Hold
36
0.01% 59
2021
Q4
$16.7K Hold
36
0.01% 65
2021
Q3
$13.4K Buy
+36
New +$13.7K 0.01% 71

Other funds holding ELV

MilWealth Group's ELV Position: Q2 2022 in Review

MilWealth Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 36 shares — an estimated $17.7K sold.

MilWealth Group first reported a position in ELV in Q3 2021 and held it in 3 quarters. The position peaked at $17.7K in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • MilWealth Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • MilWealth Group sold 36 Elevance Health shares in Q2 2022, an estimated $17.7K.
  • MilWealth Group first reported a position in Elevance Health in Q3 2021 and held it in 3 quarters.
  • MilWealth Group's Elevance Health position peaked at $17.7K in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on MilWealth Group's 13F filing for Q2 2022, filed 9 May 2023.